首页> 中文期刊> 《陕西医学杂志》 >全胃切除联合脾脏切除术根治进展期贲门癌的适应证选择

全胃切除联合脾脏切除术根治进展期贲门癌的适应证选择

         

摘要

目的:探讨进展期贲门癌根治术联合脾脏切除术的适应证及意义.方法:分析26例进展期贲门癌行全胃切除患者的临床资料,根据脾脏是否切除分为切脾组(n=10)和保脾组(n=16),比较两组患者手术时间、住院时间、术后并发症以及脾门淋巴结转移情况.结果:切脾组手术时间、住院时间和膈下感染发生率均明显高于保脾组(P<0.05).切脾组与保脾组术后病理检查出的第10、11组淋巴结转移率的差异无统计学意义(P>0.05).结论:贲门癌根治术时,脾脏和脾血管受侵是联合脾脏切除的合理适应证.%Objective :To investigate the clinical value and evaluate the complication of splenectomy in radical resection for Cardiac Cancer. Methods: Twenty-six patients with Cardiac Gancer were studied and classified into total gastrectomy with splenectomy (TGS) group (n= 10) and total gastrectomy without splenectomy (TG )group (n = 16). The operation time, hospitalized duration,complications, and lymphe node metastasis at the spleen hilus were compared between two groups. Results: The operation time,hospitalized duration and subphrenic infection rate in the TGS group were significantly higher than those in the TG group (P <0. 05). The rate of lymph node metasitasis of No. 10 and No. 11 in the TG group was not different from that in TGS group (P>O. 05). Conclusion: Direct spleen and its vessel invasion are the reasonable indication of splenectomy in radical resection for Cardiac Cancer.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号